![Nicola Santoro MD, PhD](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/25114.jpg)
Nicola Santoro MD, PhD
Assistant Professor of Pediatrics, Yale University, New Haven, Connecticut; Pediatric Associate Editor, International Journal of ObesityNicola Santoro is a Pediatrician with a research interest in obesity and its metabolic complications. He is currently studying the effect of gut microbiome on the body composition and the metabolic pathways leading to obesity, type 2 diabetes and nonalcoholic fatty liver (NAFLD) in obese youth. He is also interested in defining the metabolic phenotype of youth with NAFLD and testing how common and rare variants in certain genes (PNPLA3, GCKR, TM6SF2 etc.) may interact with the environment to convey susceptibility to pediatric fatty liver disease. His research is funded by NIH, AHA, JDRF and Allen foundation. He serves as peer reviewer for several journals and funding agencies.
Disclosures
No disclosures reported.Recent Contributions to PracticeUpdate:
- Weight in Children and Youth and Type 2 DM Risk
- Adiposity Increase From Childhood to Adulthood Predicts an MONW Phenotype
- Impact of Birth Weight on Metabolic Syndrome in Adolescents
- BMI Change During Puberty Is an Important Determinant of Adult Type 2 Diabetes Risk in Men
- The Prevalence and Risk Factors of Overweight and Obesity in Adolescents With Type 1 Diabetes